Bonkowsky H L, Pomeroy J S
Hepatology and Metabolism Research Laboratory, VA Hospital of White River Jct., Vermont 05001, USA.
Anal Biochem. 1978 Nov;91(1):82-91. doi: 10.1016/0003-2697(78)90818-7.
Conditions required for optimal assay of low levels of activity of hepatic delta-aminolevulinic acid synthetase have been studied, comparing dilute homogenates of mouse, rat, and human livers. The assay method used was a modification of that described by Ebert et al. (Biochim, Biophys, Acta (1970) 208, 236-250), and livers were studied from both untreated animal and human subjects and subjects pretreated with porphyrinogenic compounds. In homogenates of mouse and human but not rat liver, maximal rates of delta-aminolevulinic acid formation required addition to the incubation mixture of an exogenous system for succinyl-CoA generation. The requirement for this generating system was increased if livers from pretreated subjects were frozen and stored prior to assay, suggesting that the endogenous capacity for succinyl-CoA generation was more labile than delta-aminolevulinic acid synthetase under these conditions. Of the metabolic inhibitors tested (F-, malonate, and arsenite), only F- (100 mM final concentration) enhanced activity. Increasing the permeability of mitochondria by quick freeze-thawing of fresh homogenates just before assay did not increase the rate of delta-aminolevulinic acid formation.
研究了对肝脏δ-氨基-γ-酮戊酸合成酶低水平活性进行最佳测定所需的条件,比较了小鼠、大鼠和人类肝脏的稀释匀浆。所使用的测定方法是对Ebert等人(《生物化学与生物物理学学报》(1970年)208卷,236 - 250页)所述方法的改进,研究了未经处理的动物和人类受试者以及用卟啉生成化合物预处理过的受试者的肝脏。在小鼠和人类肝脏匀浆中,但大鼠肝脏匀浆中未出现这种情况,δ-氨基-γ-酮戊酸形成的最大速率需要向孵育混合物中添加用于生成琥珀酰辅酶A的外源系统。如果在测定前将预处理受试者的肝脏冷冻保存,对该生成系统的需求会增加,这表明在这些条件下,琥珀酰辅酶A生成的内源性能力比δ-氨基-γ-酮戊酸合成酶更不稳定。在所测试的代谢抑制剂(氟离子、丙二酸和亚砷酸盐)中,只有氟离子(终浓度100 mM)能增强活性。在测定前通过对新鲜匀浆进行快速冻融来增加线粒体的通透性,并没有提高δ-氨基-γ-酮戊酸的形成速率。